Format

Send to

Choose Destination
Psychiatr Q. 1995 Spring;66(1):87-95.

Bromocriptine and psychosis: a literature review.

Author information

1
Tulane Medical Center, Department of Psychiatry and Neurology, Tulane University, New Orleans, Louisiana.

Abstract

Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactinomas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.

PMID:
7701022
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center